Physician profile
Amber L Post
NPI 1760556302
$10,889.56
in general payments reported to CMS, 2019-2025
28 companies · $451 in 2025
The $451 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.56 · 2020: $9,284 · 2021: $245 · 2022: $167 · 2023: $375 · 2024: $290 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,443.60 | 2020-2023 | Da Vinci Surgical System |
| Abbvie INC. | $158.74 | 2021-2025 | |
| Organon LLC | $135.56 | 2021-2025 | Nexplanon, Nuvaring |
| Astellas Pharma US INC | $134.75 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $108.31 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $106.05 | 2021-2023 | |
| Daiichi Sankyo INC. | $100.69 | 2024-2025 | Injectafer |
| Sage Therapeutics, LLC | $81.22 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $74.25 | 2023-2025 | Slynd |
| Medtronic, INC. | $72.89 | 2022-2023 | Ligasure |
| Myriad Women'S Health, INC. | $56.91 | 2023 | |
| Exact Sciences Corporation | $54.39 | 2023-2024 | Cologuard Collection Kit |
| Conmed Corporation | $50.00 | 2025 | Airseal |
| Bayer Healthcare Pharmaceuticals INC. | $41.55 | 2019-2025 | |
| Therapeuticsmd, INC. | $29.61 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $24.57 | 2019 | |
| Alydia Health | $23.98 | 2021 | |
| Pharmacosmos Therapeutics INC. | $23.04 | 2023 | Monoferric |
| Smith+Nephew, INC. | $22.68 | 2025 | Pico 14 |
| Merck Sharp & Dohme LLC | $21.39 | 2023 | Gardasil 9 |
| Myovant Sciences INC. | $17.82 | 2022 | |
| Hologic Sales and Service, LLC | $17.52 | 2024 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Axonics, INC. | $17.39 | 2023 | Axonics |
| Lilly USA, LLC | $16.78 | 2025 | Mounjaro, Zepbound |
| Ethicon US, LLC | $16.16 | 2024 | Dermabond Prineo, Stratafix |
| Kci USA, INC. | $15.58 | 2019 | |
| Mayne Pharma Commercial LLC | $12.29 | 2023 | |
| Axsome Therapeutics, INC. | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Post listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.